ascopubs.org3d
Baseline fracture risk for prostate cancer patients initiating long-term androgen deprivation therapy.
Efficacy of 177Lu-PSMA-617 with or without ARPIs for the treatment of mCRPC: VISION secondary analysis. Safety profile of lutetium-177 in patients with impaired renal function: A retrospective ...
ascopubs.org5d
Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2024.3
Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.3 ...
ascopubs.org5d
Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.3
Reply to: Treatment Intensification Based on Residual Disease in Elderly Patients With AML ...
ascopubs.org5d
Challenges in the Management of Advanced Prostate Cancer
Assessing Clinical Value of New Treatment Strategies: ESMO-MCBS and ASCO-VF Evaluation in Phase III Trials at ASCO Annual Meeting 2022 Fig 1. Challenges in the management of advanced prostate cancer.
ascopubs.org5d
Erratum: Comparison of PREMM5 and PREMMplus Risk Assessment Models to Identify Lynch Syndrome
The article by Biller et al entitled “Comparison of PREMM5 and PREMMplus Risk Assessment Models to Identify Lynch Syndrome” (JCO Precision Oncology 10.1200/PO-24 ...
ascopubs.org7d
Where Is the Future of Adjuvant Therapy for Hepatocellular Carcinoma?
Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2024.3 The following represents disclosure information provided by authors of this manuscript ...
ascopubs.org7d
Erratum: Comparison of PREMM5 and PREMMplus Risk Assessment Models to Identify Lynch Syndrome
Addressing Bias in Feature Importance: A Hybrid Approach for Risk Prediction in Prognostic Survival Models ...
ascopubs.org9d
Reduction of systemic chemotherapy by primary retroperitoneal lymph node dissection in low volume metastatic seminoma.
Validation of new prognostic factors for relapse in patients with clinical stage I seminoma. Time to real-world progression (TTrwP) among patients (pts) with relapsed/refractory (R/R) testicular germ ...
ascopubs.org12d
Erratum: Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update Clinical Insights
How Should We Manage the Impact of Antimicrobial Resistance in Patients With Cancer? An Oncological and Infectious Disease Specialist Point of View ...
ascopubs.org12d
Socioeconomic Burden of Ovarian Cancer in 11 Countries
Survival and Its Predictors Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma in Ethiopia: A 6-Year Follow-Up Study Ovarian cancer remains among the most aggressive ...
ascopubs.org12d
Oral Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors: Call to Action
Perspectives of Lymphoma Survivors and Oncology Care Providers on Survivorship Care: A Qualitative Study Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, offering new hope ...
ascopubs.org13d
Application of ML models to predict postoperative outcomes in renal cell carcinoma.
Patterns of hospital admissions and readmissions due to immune-related adverse events in patients with genitourinary cancers. Understanding health inequalities based on socio-economic factors and ...